Variables | Categories | Univariate analysis | P | Multivariate analysis | P | ||
---|---|---|---|---|---|---|---|
HRa | 95% CIb | HRa | 95% CIb | ||||
Age | <60 | Â | Â | Â | Â | Â | Â |
 | ≥60 | 1.131 | 0.779-1.640 | 0.518 | – | – | – |
FIGO stage | I+II | Â | Â | Â | Â | Â | Â |
 | III+IV | 1.882 | 1.261-2.809 | 0.002* | 1.710 | 1.144-2.557 | 0.009* |
Grade | G1 | Â | Â | Â | Â | Â | Â |
 | G2 | 1.171 | 0.686-1.997 | 0.563 | – | – | – |
 | G3 | 1.419 | 0.864-2.330 | 0.166 | – | – | – |
Histological type | Serous | Â | Â | Â | Â | Â | Â |
 | Nonserous | 0.852 | 0.596-1.218 | 0.380 | – | – | – |
LVS involvement | Negative | Â | Â | Â | Â | Â | Â |
 | Positive | 1.944 | 1.246-3.033 | 0.003* | 1.410 | 0.935-2.127 | 0.101 |
Lymph node metastasis | Negative | Â | Â | Â | Â | Â | Â |
 | Positive | 1.638 | 1.091-2.461 | 0.017* | 1.578 | 1.001-2.488 | 0.050 |
Basigin-2 | Low | Â | Â | Â | Â | Â | Â |
 | High | 2.046 | 1.388-3.017 | <0.001* | 1.758 | 1.179-2.619 | 0.006* |